ArticleJournal of molecular modeling2026
Deciphering SHP-2 conformational switching via elastic network models and transfer entropy analysis.
Article in Journal of molecular modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
contextSrc homology 2 domain-containing protein tyrosine phosphatase-2 (SHP-2), a non-receptor protein tyrosine phosphatase encoded by PTPN11, functions as a central regulator of the Ras-MAPK, JAK-STAT, and PI3K-AKT signaling pathways. Its gain-of-function mutations, such as E76K, drive aberrant activation in multiple cancers, making it an attractive therapeutic target. While molecular dynamics simulations have provided atomic-level insights into SHP-2 conformational dynamics, they are computationally prohibitive for systematically characterizing large-scale domain rearrangements and allosteric communication networks. Here, we employed an equal-weighted multi-parameter Gaussian network model (ewmGNM) to investigate the two lowest-frequency modes governing the functional dynamics of SHP-2 in three key systems: the wild-type closed (autoinhibited) conformation, the oncogenic E76K mutant in its open (active) conformation, and its complex with the allosteric inhibitor SHP099. By focusing on low-frequency modes, we computed residue fluctuations, dynamic cross-correlations, and transfer entropy to map directional information flow and allosteric communication landscapes. Our results demonstrate that the E76K mutation globally increases protein flexibility and disrupts inter-domain coupling, particularly at the N-SH2/PTP interface, whereas SHP099 binding largely restores the closed state dynamics but retains mutation-induced residual flexibility. Transfer entropy analysis reveals a conformation-dependent reorganization of information flow, with the open state exhibiting that the N-SH2 domain possibly acts as a new entropy source, tentatively suggesting its potential as a novel allosteric site. These findings provide a mechanistic understanding of SHP-2 conformational regulation and offer a theoretical basis for the design of allosteric inhibitors targeting this open state site.
methodsProtein crystal structures were downloaded from the Protein Data Bank. The ewmGNM and the conventional GNM were implemented using custom scripts written in MATLAB R2024b. Protein dynamics data were mapped using custom Python scripts in PyMOL.
Indexed as
Identifiers
42742803What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.